Reditus Laboratories

Reditus Laboratories is renowned for its exceptional efficiency, a testament to the visionary leadership that established the company. By providing essential protective gear such as glasses, gowns, and masks and conducting accurate testing on a wide scale, Reditus significantly impacted the spread of Covid.

Even before the nation became fixated on the Covid pandemic, Reditus had already established itself as a premier testing lab in podiatry. Building on this success, the company expanded into urology and histology testing. Histology tests are crucial in helping doctors diagnose abnormalities in human cells or tissues, including identifying certain microorganisms responsible for infection, disease, and even cancer.

Reditus utilized state-of-the-art equipment and advanced clinical laboratory procedures to analyze diverse skin biopsies, wound samples, and wart specimens. The company’s commitment to employing cutting-edge technology allowed for accurate diagnoses and provided valuable insights into effective disease management and injury treatment.

Reditus was initially established to provide pathology services to both patients and clinicians. The diagnostic testing they offer profoundly impacts every stage of patient care, ranging from the initial diagnosis to the management of chronic diseases, as well as providing curative solutions for acute injuries or illnesses. Their corporate mission has always revolved around offering accurate laboratory testing that is easily accessible, ensuring a swift turnaround for patients.

In addition to serving referred and walk-in patients, Reditus Labs emerged as a national leader in Covid laboratory testing for universities and local school districts. Their comprehensive turnkey solution included personal protective equipment, on-site testing staff, and a secure web-based portal granting private test results access.

Recognizing the critical role of Covid booster shots in the country’s economic recovery, Reditus forged partnerships with corporate and government entities to provide on-site employee testing services. The company offers customized services because each site and population may face unique challenges and requirements. It worked directly with HR departments to implement effective infectious disease testing and surveillance programs. This included their specialized “Reditus FluV19” test to detect Covid, Influenza A, and Influenza B.

When mass testing of the public became necessary, Reditus Laboratories swiftly organized and deployed concierge events at public locations. These services encompass convenient drive-up, walk-in, and by-appointment testing options for the general population. With a remarkable capacity to conduct over 40,000 Covid-19 tests per day and a specificity and sensitivity rate exceeding 98.9%, Reditus played a significant role in ensuring community safety and facilitating the return to normalcy.